![Uri Weinberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uri Weinberg
Chief Tech/Sci/R&D Officer at
NOVOCURE LIMITED
Net worth: 5 M $ as of 2026-05-30
Profile
Currently, Uri Weinberg is Chief Science Officer at NovoCure Ltd. Dr. Weinberg received a doctorate from Israel Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVOCURE LTD. 0.23% | 2026-04-05 | 267,190 ( 0.23% ) | 5 M $ | 2026-05-30 |
Uri Weinberg active positions
| Companies | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 2026-04-07 |
Training of Uri Weinberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
21
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Israel Institute of Technology
 Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Uri Weinberg
